FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20251119E00346
1. Date of relevant event: 14/11/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02279
4. Name of listed corporation: Yonghe Medical Group Co., Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 525,472,416
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Zhang
(Other names) Yu
10. Name of director (Chinese): 張玉 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1305There has been a change in nature of your interest in the shares because:
you have provided an interest in the shares as security to a person other than a qualified lender
 
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
 
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
 
2,250,000         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position181,531,91634.55
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position181,531,91634.55
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position161,531,916
2201Interest of corporation controlled by you
Long position20,000,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Shanghai Yuhe Technology Company Limited2nd Floor, No. 979, Yunhan Road, Lingang New Area, China (Shanghai) Pilot Free-Trade Zone, The People's Republic of ChinaZhang Yu100.00N
Long position20,000,000
Shanghai Yuxin Technology Partnership (Limited Partnership)24 Yangxin East Road, Pudong New Area, Shanghai, The People's Republic of ChinaShanghai Yuhe Technology Company Limited100.00N
Long position20,000,000
Yunuo Technology Holdings LimitedP.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsShanghai Yuxin Technology Partnership (Limited Partnership)100.00Y
Long position20,000,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
The ZY TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position161,531,916
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: On 14 November 2025, ZY Investment Capital Ltd has agreed to deliver 2,250,000 shares of Yonghe Medical Group Co., Ltd. to Equities First Holdings LLC ("EFH") to be held as collateral for a loan to be granted by EFH. ZY Investment Capital Ltd is indirectly wholly owned by Trident Trust Company (Singapore) Pte Limited as the trustee of The ZY Trust. The ZY Trust is a discretionary trust set up by Mr. Zhang Yu as the settlor and founder.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 19/11/2025
(dd/mm/yyyy)